Instruction for use: Immunoglobulinum humanum contra encephalitidem ixodicum fluidumI want this, give me price
Dosage form: Solution for intramuscular injection
Active substance: Immunoglobulinum antiencephaliticum
J06BB12 Human immunoglobulin against tick-borne encephalitis
The nosological classification (ICD-10)
A84 Tick-borne viral encephalitis: Tick-borne encephalitis; Tick-borne encephalitis
Composition and release form
Immunologically active protein fraction isolated from human donor plasma or serum containing specific antibodies to tick-borne encephalitis virus. The protein concentration is 100 mg / ml; Stabilizer-glycine (22.5 ± 7.5 mg / ml). Liquid in ampoules of 1 ml, in a package of 10 pcs.
Transparent or slightly opalescent liquid, colorless or with a weak yellow color. Does not contain preservative and antibiotics, virologically safe.
Mode of action - immunostimulating.
Indication of the Immunoglobulinum humanum contra encephalitidem ixodicum fluidum
Tick-borne encephalitis (emergency prevention and treatment).
Rarely: hyperemia, fever, allergic reactions.
Dosing and Administration
IM, for prevention (once): at the age of 12 years - 1 ml, from 12 to 16 years - 2 ml, from 16 years and older - 3 ml. For treatment - in the first days of 3 ml with an interval of 10-12 hours (before the temperature drops).
After the introduction, patients should be monitored for 30 minutes (the possibility of developing allergic reactions). Preparations should be made for anti-shock therapy. The preparation is not suitable for use in ampoules with broken integrity and marking, with changing physical properties (turbidity, intense staining, presence of non-breakable flakes), expired shelf life, improper storage.
Storage conditions of the drug Immunoglobulinum humanum contra encephalitidem ixodicum fluidum
At a temperature of 2-8 ° C (do not freeze).
Keep out of the reach of children.
Shelf life of the drug Immunoglobulinum humanum contra encephalitidem ixodicum fluidum
Do not use after the expiry date printed on the package.